financial statements
The full income statement, balance sheet, and cash-flow statement for HCA Healthcare Inc. (HCA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 75.6B YoY+7.1% | 70.6B YoY+8.7% | 65.0B YoY+7.9% | 60.2B YoY+2.5% | 58.8B YoY+14.0% | |
| Selling, general & administrative | 548M YoY+30.2% | 421M YoY+19.3% | 353M YoY+15.0% | 307M YoY-8.9% | 337M YoY-19.0% | |
| General & administrative | 548M YoY+30.2% | 421M YoY+19.3% | 353M YoY+15.0% | 307M YoY-8.9% | 337M YoY-19.0% | |
| Amortization of intangibles | 12.0M YoY-25.0% | 16.0M YoY-20.0% | 20.0M YoY-54.5% | 44.0M YoY+76.0% | 25.0M YoY-3.8% | |
| Interest expense | 2.25B YoY+9.1% | 2.06B YoY+6.3% | 1.94B YoY+11.3% | 1.74B YoY+11.2% | 1.57B YoY-1.1% | |
| Equity-method income | 78.0M YoY+239.1% | 23.0M YoY+4.5% | 22.0M YoY-51.1% | 45.0M YoY-60.2% | 113M YoY+109.3% | |
| Pre-tax income | 9.83B YoY+15.4% | 8.52B YoY+10.6% | 7.71B YoY-10.2% | 8.58B YoY-12.7% | 9.83B YoY+81.1% | |
| Income tax | 2.05B YoY+9.9% | 1.87B YoY+15.5% | 1.61B YoY-7.5% | 1.75B YoY-17.3% | 2.11B YoY+102.5% | |
6.78B YoY+17.8% | 5.76B YoY+9.9% | 5.24B YoY-7.1% | 5.64B YoY-18.9% | 6.96B YoY+85.3% | ||
$28.33 YoY+28.8% | $22.00 YoY+16.0% | $18.97 YoY-0.9% | $19.15 YoY-9.5% | $21.16 YoY+93.6% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
15.8B YoY-3.8% | 16.4B YoY+10.0% | 14.9B YoY+9.4% | 13.6B YoY+0.7% | 13.5B YoY+9.8% | ||
60.7B YoY+2.0% | 59.5B YoY+5.9% | 56.2B YoY+7.2% | 52.4B YoY+3.3% | 50.7B YoY+6.8% | ||
16.4B YoY+7.7% | 15.2B YoY+19.9% | 12.7B YoY+27.8% | 9.90B YoY+3.3% | 9.58B YoY+10.1% | ||
45.6B YoY+0.0% | 45.6B YoY+0.0% | 45.6B YoY+0.0% | 45.6B YoY+0.0% | 45.6B YoY+0.0% | ||
-6.03B YoY-141.2% | -2.50B YoY-40.9% | -1.77B YoY+35.9% | -2.77B YoY-196.6% | -933M YoY-263.1% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
12.6B YoY+20.2% | 10.5B YoY+11.5% | 9.43B YoY+10.7% | 8.52B YoY-4.9% | 8.96B YoY-3.0% | ||
-4.99B YoY-1.1% | -4.93B YoY+7.2% | -5.32B YoY-56.9% | -3.39B YoY-28.2% | -2.64B YoY+22.1% | ||
-8.55B YoY-86.6% | -4.58B YoY-11.9% | -4.09B YoY+27.6% | -5.66B YoY+15.0% | -6.66B YoY-42.3% | ||
| FX effect on cash | 9.00M YoY+1000.0% | -1.00M YoY-114.3% | 7.00M YoY+135.0% | -20.0M YoY-566.7% | -3.00M YoY-130.0% | |
| Net change in cash | -893M YoY-189.5% | 998M YoY+3596.3% | 27.0M YoY+105.0% | -543M YoY-58.8% | -342M YoY-129.2% | |
| Interest paid | 2.21B YoY+13.9% | 1.94B YoY+2.4% | 1.89B YoY+13.8% | 1.66B YoY+10.7% | 1.50B YoY-6.5% | |
| Income taxes paid | 1.74B YoY-5.6% | 1.84B YoY+33.0% | 1.39B YoY+18.0% | 1.18B YoY-46.2% | 2.18B YoY+117.8% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 107B YoY+40.1% | 76.0B YoY+4.9% | 72.5B YoY+6.8% | 67.8B YoY-15.1% | 79.9B YoY+43.6% | |
| P/E | 15.7× YoY+19.0% | 13.2× YoY+2.5% | 12.9× YoY+0.5% | 12.8× YoY+11.5% | 11.5× YoY-22.5% | |
| P/S | 1.4× YoY+30.9% | 1.1× YoY-7.6% | 1.2× YoY+1.2% | 1.2× YoY-15.3% | 1.4× YoY+25.9% | |
| P/FCF | 13.9× YoY+2.7% | 13.5× YoY-19.9% | 16.8× YoY+2.0% | 16.5× YoY+11.1% | 14.8× YoY+70.7% | |
| Earnings yield | 6.4% YoY-15.9% | 7.6% YoY-2.4% | 7.8% YoY-0.5% | 7.8% YoY-10.3% | 8.7% YoY+29.0% | |
| FCF yield | 7.2% YoY-2.7% | 7.4% YoY+24.8% | 5.9% YoY-1.9% | 6.1% YoY-10.0% | 6.7% YoY-41.4% | |
| Dividend yield | 0.6% YoY-29.9% | 0.9% YoY-0.8% | 0.9% YoY-5.0% | 0.9% YoY+24.9% | 0.7% YoY+185.8% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: HCA's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all HCA filings on SEC EDGAR → Not investment advice.
